Chief Executive Officer #
Dr Michael Raymont #
Dr. Raymont’s career has spanned leadership roles in venture capital, agricultural and healthcare investment, tech company leadership and senior Government service, where he ran the National Research Council (NRC), Canada’s largest R&D organization. With a background in both science and business, Dr. Raymont has advised corporations and governments, worked extensively internationally and has sat on the boards of over 50 public and private companies.
Chief Medical Officer #
Dr Malcolm Barratt-Johnson #
Malcom has over 22 years in the pharmaceutical industry specialising in Medical Affairs, Product Development and Regulatory Strategy. Malcom has worked extensively in senior positions to both Industry and Government. Holding positions at AstraZeneca, Roche, and the UK Medicines Regulatory Agency (MHRA) and European Medicines Evaluation Agency (EMEA). More recently Malcom, as a Clinical Specialist chaired the European Commission’s Biomedical Research Programme (Horizon 2020). He has also lectured in both Europe and the United States on Medicine & Drug Development.
Principal Investigator #
Professor Sara Tai #
A Senior Lecturer in Clinical Psychology at the University of Manchester and Consultant Clinical Psychologist at Cheadle Royal Hospital and Greater Manchester West Mental Health NHS Foundation Trust. Sara is an experienced practitioner, trainer, and supervisor of transdiagnostic approaches for working with people with serious mental health problems and their families; providing one-to-one interventions, group interventions, and family work. She has an international reputation as a trainer in CBT and has published widely in this area, including the book “A principles-based approach to counseling and psychotherapy”.
Chief Operating Officer #
Santoke Naal #
25+ years experience in executive and operational management, marketing, brand building, and retail distribution in the European cosmetic and pharmaceutical markets with Pharma giants such as Novartis and Bristol Myers. Recently, Santoke was the Managing Director for Pierre Fabre UK, the global botanical extracts specialist. Pierre Fabre comprises a range of dermocosmetics with leading brands, as well as an extensive range in healthcare and prescription medicines.
Chief Development Officer #
Ali Gulamhusein #
15+ years of engineering experience in the development and commercialization of novel process technologies in oil and gas, pulp and paper, electrochemistry and pharmaceutical sectors. In 2011, Ali founded AGEIAS Engineered Systems Ltd., an EPCM focused on the design and build of modular systems for proof of concept, demonstration, and commercial prototypes servicing clients from academic institutions, contract research organizations and laboratories. Ali has extensive experience in the management of both short-term and multi-year R&D programs with a strong track record of commercialization.
